Saskatoon Cancer Center

Saskatoon, Saskatchewan S7N4H4

2 studies enrolling now · 7 studies all time

What they study most

Glioblastoma, Lymphoma, Non-Hodgkin's, Metastatic Colorectal Cancer, Metastatic Renal Cell Cancer, Multiple Myeloma, Refractory Diffuse Large B-cell Lymphoma, Relapsed Diffuse Large B-cell Lymphoma

Studies at this site

• A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments — Recruiting now
• DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma — Recruiting now
• A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer — Running, not enrolling
• Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma — Completed
• A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1 — Completed
• A Study of Revlimid in the Treatment of Non-Hodgkin's Lymphoma — Completed
• Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy — NO_LONGER_AVAILABLE